HUM vs SAVA · P/E 39, rev $117.76B vs $115.0M cap
Humana Inc (HUM) versus Cassava Sciences Inc (SAVA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Cassava Sciences Inc (SAVA) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
SAVA does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SAVA currently screens at market cap $115.0M.
Not investment advice. Open the HUM and SAVA stock pages for the full models.
Not investment advice.